Sign inJoin waitlistJoin the waitlist

Julia Fehniger

Physician · Legacy Salmon Creek Medical Center

Credentials: · · · · · · ·

History

Legacy Salmon Creek Medical Center · Providence Health & Services - Oregon
2023–Present

Gynecologic Oncology
2020–2023
Obstetrics and Gynecology
University of Chicago Medical Center
2016–2020
University of Michigan Medical School
2009–2013

Research

Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers
Journal of Genetic Counseling · 2013 · First of 5 authors · 91 citations
COVID-19 outcomes of patients with gynecologic cancer in New York City
Cancer · 2020 · 49 citations
Small cell cancers of the female genital tract: Molecular and clinical aspects
Review · Gynecologic Oncology · 2018 · 47 citations

Bhavana Pothuri
7 papers
Anne Knisely
4 papers · 4 as a resident
Jason Wright
4 papers
Jennifer McEachron
4 papers · 4 as a fellow
Lisa Gabor
4 papers · 4 as a fellow
MB
Mary Beattie
4 papers
Olivia Lara
4 papers · 4 as a fellow
RO
Roisin O'Cearbhaill
4 papers
Sara Isani
4 papers
Caitlin Carr
3 papers · 3 as a resident
DL
Douglas Levine
3 papers
JJ
Justin Jee
3 papers

Clinical trials

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Site PI · Recruiting
NRG Oncology
2020–2047